It's good, but I'm not terribly excited about starting another phase 1 trial when both B-OM and B-ABSSSI are ready to start phase 3 but have not yet been partnered. B-UP had great phase 2 results but we already gave away 94% of that indication.
I know, I know, B-UC will be different. I hope so.
Market Data 
Markets 
AI
